NCT03577327 The Gut and Skin Microbiome in Vitiligo Disease Progression
| NCT ID | NCT03577327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Vitiligo |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-05-30 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2019-05-30 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.
Eligibility Criteria
Inclusion Criteria: * Patients with and/or without vitiligo lesional expansion over the past year. * Age/sex-matched controls who do not have a diagnosis of vitiligo * Subjects who are age 18-89 years of age at time of enrollment * Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443) Exclusion Criteria: * Subjects who are younger than 18 years of age or 90 years of age or older * Subjects who are unable to give consent
Contact & Investigator
I. Caroline Le Poole
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT03577327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Vitiligo. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03577327 currently recruiting?
Yes, NCT03577327 is actively recruiting participants. Contact the research team at NUdermatologyCTU@northwestern.edu for enrollment information.
Where is the NCT03577327 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT03577327 clinical trial?
NCT03577327 is sponsored by Northwestern University. The principal investigator is I. Caroline Le Poole at Northwestern University. The trial plans to enroll 100 participants.